167 related articles for article (PubMed ID: 15735806)
21. Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.
Wong PC; Crain EJ; Watson CA; Wexler RR; Lam PY; Quan ML; Knabb RM
J Thromb Thrombolysis; 2007 Aug; 24(1):43-51. PubMed ID: 17323133
[TBL] [Abstract][Full Text] [Related]
22. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
23. Effect of clopidogrel on platelet aggregation and intimal hyperplasia following carotid endarterectomy in the rat.
Bledsoe SL; Brown AT; Davis JA; Chen H; Eidt JF; Moursi MM
Vascular; 2005; 13(1):43-9. PubMed ID: 15895674
[TBL] [Abstract][Full Text] [Related]
24. Comparative arterial antithrombotic activity of clopidogrel and acetyl salicylic acid in the pig.
Samama CM; Bonnin P; Bonneau M; Pignaud G; Mazoyer E; Bailliart O; Maffrand JP; Viars P; Caen JP; Drouet LO
Thromb Haemost; 1992 Nov; 68(5):500-5. PubMed ID: 1455394
[TBL] [Abstract][Full Text] [Related]
25. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ
J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167
[TBL] [Abstract][Full Text] [Related]
26. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
[TBL] [Abstract][Full Text] [Related]
27. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
Vilahur G; Pena E; Padró T; Badimon L
Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
[TBL] [Abstract][Full Text] [Related]
28. W1, a Novel Oral Antiplatelet Agent With Less Resistance Than Clopidogrel.
Ge P; Du L; Han C; Li H; Feng Y; Han J; Wang Z; Xiong L; Yuan M; Liu Y
J Cardiovasc Pharmacol; 2017 Feb; 69(2):110-117. PubMed ID: 27930430
[TBL] [Abstract][Full Text] [Related]
29. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
[TBL] [Abstract][Full Text] [Related]
30. Long-term clopidogrel administration following severe coronary injury reduces proliferation and inflammation via inhibition of nuclear factor-kappaB and activator protein 1 activation in pigs.
Pels K; Schwimmbeck PL; Rosenthal P; Loddenkemper C; Dang-Heine C; Rauch U; Martens H; Schultheiss HP; Dechend R; Deiner C
Eur J Clin Invest; 2009 Mar; 39(3):174-82. PubMed ID: 19260946
[TBL] [Abstract][Full Text] [Related]
31. Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease.
Jain N; Li X; Adams-Huet B; Sarode R; Toto RD; Banerjee S; Hedayati SS
Am J Cardiol; 2016 Feb; 117(4):656-663. PubMed ID: 26725101
[TBL] [Abstract][Full Text] [Related]
32. Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.
Yang YJ; Zhao JL; You SJ; Wu YJ; Jing ZC; Yang WX; Meng L; Wang YW; Gao RL
Heart; 2006 Aug; 92(8):1131-7. PubMed ID: 16387825
[TBL] [Abstract][Full Text] [Related]
33. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
[TBL] [Abstract][Full Text] [Related]
34. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial.
Lim E; Cornelissen J; Routledge T; Kirtland S; Charman SC; Bellm S; Munday H; Khan O; Masood I; Large S
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):432-5. PubMed ID: 15354104
[TBL] [Abstract][Full Text] [Related]
35. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
Usman MH; Notaro LA; Nagarakanti R; Brahin E; Dessain S; Gracely E; Ezekowitz MD
Am J Cardiol; 2009 Apr; 103(8):1107-12. PubMed ID: 19361598
[TBL] [Abstract][Full Text] [Related]
36. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel.
Cohen MG; Rossi JS; Garbarino J; Bowling R; Motsinger-Reif AA; Schuler C; Dupont AG; Gabriel D
Thromb Res; 2011 Oct; 128(4):335-40. PubMed ID: 21621252
[TBL] [Abstract][Full Text] [Related]
37. The antithrombotic effect of melagatran in combination with clopidogrel and/or aspirin (carotid artery primary thrombosis study).
Hong TT; Huang J; Driscoll E; Lucchesi BR
J Cardiovasc Pharmacol; 2005 Oct; 46(4):526-33. PubMed ID: 16160608
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
39. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
[TBL] [Abstract][Full Text] [Related]
40. Earlier application of loading doses of aspirin and clopidogrel decreases rate of recurrent cardiovascular ischemic events for patients undergoing percutaneous coronary intervention.
Tang FK; Lin LJ; Hua N; Lu H; Qi Z; Tang XZ
Chin Med J (Engl); 2012 Feb; 125(4):631-8. PubMed ID: 22490487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]